Changes in the immune system in rodent models of depression

International Journal of Neuropsychopharmacology

Volumn 5, Issue 4, 2002, Pages 345-356

  Leonard, Brian E ^a,b   Song, Cai ^c  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Brain monoamines; Depression; Pro inflammatory cytokines; Rodent models

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN MONOAMINE; CYTOKINE; GAMMA INTERFERON; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NEUROTRANSMITTER; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR;

AMNESIA; ANIMAL BEHAVIOR; ANIMAL MODEL; BRAIN DEPTH STIMULATION; CENTRAL NERVOUS SYSTEM; CYTOKINE RELEASE; DEPRESSION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; NONHUMAN; OLFACTORY BULBECTOMY; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; REGULATORY MECHANISM; REVIEW; REWARD; RODENT; STRESS; TRANQUILIZING ACTIVITY;

AMNESIA; ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; BRAIN; CYTOKINES; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE SYSTEM; MICE; OLFACTORY BULB; RATS; REWARD; STRESS, PSYCHOLOGICAL;

EID: 0036902058     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145702003140     Document Type: Review

References (101)

1. Ader R, Felton DL, Cohen N (1991). Psychoneuroimmunology (2nd Edn). San Diego, CA: Academic Press.
2. Agren H, Reibring L (1994). PET studies of presynaptic monoamine metabolism in depressed patients and healthy volunteers. Pharmacopsychiatry 27, 2-6.
3. Akiyoshi M, Shimizu Y, Sarto M (1990). IL-1 increases norepinephrine in the spleen and lungs in rats. Biochemical and Biophysical Research Communications 173, 1266-1270.
4. Albrecht J, Helderman JH, Schlesser MA, Rush AJ (1985). A controlled study of cellular immune function in affective disorders before and during somatic therapy. Psychiatry Research 15, 185-193.
5. Anisman H, Kokkindis L, Borowski T, Merali Z (1998). Differential effects of IL-1beta IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation. Brain Research 779, 177-187.
6. Anisman H, Merali Z (1999). Anhedonic and anxiogenic effects of cytokine exposure In: Dantzer R, Wollman EE, Yirminya R (Eds.), Cytokines Stress and Depression (pp. 199-233). New York: Plenum Press.
7. Arber M, Berliner S, Tamir A, Liberman E, Segal G, Puikhas J, Aronson M (1991). The state of leucocyte adhesion/aggregation in the peripheral blood: A new and independent marker of mental stress. Stress Medicine 7, 75-78.
8. Ayuso JL (1994). The use of psychotropic drugs in patients with HIV infection. Drugs 47, 599-610.
9. Banks WA, Kastin AJ (1992). The interleukins 1alpha, 1beta and 2 do not acutely disrupt the murine blood-brain barrier. International Journal of Immunopharmacology 14, 629-636.
10. Banks WA, Kastin AJ, Gutierrez EG (1993). Interleukin 1 alpha in blood has direct access to cortical brain cells. Neuroscience Letters 163, 41-44.
11. Barden N, Reul JMHM, Holsboer F (1995). Do antidepressants stabilize mood through actions on the HPA system? Trends in Neuroscience 18, 6-11.
12. Baumann H, Gouldie J (1994). The acute phase response. Immunology Today 15, 74-80.
13. Benveniste EW (1992). Inflammatory cytokines within the central nervous system: Sources function and mechanism of action. American Journal of Physiology 263 (Cell Physiology), cl-c16.
14. Blotta MH (1997). Corticosteroids inhibit IL-12 production in human monocytes and enhances their capacity to induce IL-4 CD4 + lymphocytes. Journal of Immunology 158, 5589-5595.
15. Cohen JJ, Crnic LS (1982). Glucocorticoids stress and the immune response In: Webb DR (Ed.), Immunology and the Regulation of Leucocyte Function (pp. 61-69). New York: Marcel Dekker.
16. Connor TJ, Song C, Leonard BE, Merali Z, Anisman H (1998). An assessment of the effects of central IL-1beta IL-2 IL-6 and TNFalpha on some behavioural neurochemical endocrine and immune parameters in the rat. Neuroscience 84, 923-933.
17. Connor TJ, Harkin A, Kelly J, Leonard BE (2000). Olfactory bulbectomy provokes a suppression of IL-1 beta and TNF-alpha production in response to an in vivo challenge with LPS: Effect on chronic desipramine treatment. Neuroimmunomodulation 7, 27-36.
18. Croiset G, Heijnen CJ, Veldnuis HD, DeWied D, Ballieux RE (1987). Modulation of the immune response by emotional stress. Life Science 40, 775-782.
19. Cunnick JE, Lysle DT, Aronfield A, Goodall G (1996). Cytokine actions on behaviour. In: Rothwell NJ (Ed.), Cytokines in the Nervous System (pp. 100-108). New York: R. G. Lande and Co.
20. Dantzer R, Bluthe RM, Laye S, Bret-Dibat JL, Parnet P, Kelley KW (1998). Cytokines and sickness behaviour. Annals of the New York Academy of Sciences 840, 584-590.
21. Drevets WC, Videen T, Price JL, Preskorn SH, Carmichael ST, Raichie ME (1994). A functional anatomical study of unipolar depression. Journal of Neuroscience 12, 3628-3641.
22. Dunn AJ (1988). Systemic IL-1 administration stimulates hypothalamic noradrenaline metabolism paralleling the increased plasma corticosterone. Life Science 43, 429-435.
23. Dunn AJ, Chuluyan HE (1994). Endotoxin elicits normal tryptophan and indoleamine responses but impaired catecholamine and pituitary-adrenal responses in endotoxin resistant mice. Life Science 54, 847-853.
24. Dunn AJ, Wang J, Ando T (1999). Effects of cytokines on cerebral neurotransmitters. In: Dantzer R, Wollman EE, Yrimiya R (Eds.), Cytokines Stress and Depression (pp. 117-128). New York: Kluwer Academic/Plenum Press.
25. Ebbesen F, Knudsen A (1992). The possible risk of bilirubin encephalopathy as predicted by plasma parameters in neonates with previous severe asphyxia. European Journal of Pediatrics 151, 910-912.
26. Fleshner M, Goehler LE, Hermann J, Relton JK, Maier SF, Watkins LR (1995). IL-1beta induced corticosterone elevation and hypothalamic norepinephrine depletion is vagally mediated. Brain Research Bulletin 37, 605-610.
27. Gutierrez EG, Banks WA, Kastin AJ (1993). Murine tumour necrosis factor is transported from blood to brain in the mouse. Journal of Neuroimmunology 47, 169-176.
28. Hama T, Kushima Y, Miyamato M, Takei N, Hatanaka H (1991). IL-6 improves the survival of mesencephalic catecholamines and septal cholinergic neurons from postnatal two-week old rats in culture. Neuroscience 40, 445-456.
29. Hanish UK, Seto D, Quirion R (1993). Modulation of hippocampal acetylcholine release: A potent central action of IL-2. Journal of Neuroscience 13, 3368-3374.
30. Hart BL (1988). Biological basis of behaviour in sick animals. Neuroscience and Biobehavioral Reviews 12, 123-137.
31. Hickey W, Kimura H (1988). Perivascular microglia cells of the central nervous system are bone marrow derived and present antigens in vivo. Science 238, 290-292.
32. Hickie I, Hickie C, Lloyd A, Silove D, Wakefield D (1993). Impaired in vivo immune responses in patients with melancholia. British Journal of Psychiatry 162, 651-657.
33. Hickie I, Lloyd A (1995). Are cytokines associated with neuropsychiatric syndromes in humans? International Journal of Immunopharmacology 17, 677-683.
34. Kelly J, Leonard BE (1993). Dexamethasone suppression of corticosterone secretion in olfactory bulbectomised rats. Neuropsychopharmacology 9, 137S-138S.
35. Kelly J, Wrynn AS, Leonard BE (1997). The olfactory bulbectomised rat model of depression: An update. Pharmacology and Therapeutics 74, 299-316.
36. Kent S, Bluthe RM, Kelley KW, Dantzer R (1992). Sickness behaviour as a new target for drug development. Trends in Pharmacological Science 13, 24-28.
37. Kiecolt-Glaser JK, Glaser R (1988). Methodological issues in behavioural immunology research in humans. Brain, Behavior and Immunity 2, 67-78.
38. Kiecolt-Glaser JK, Glaser R, Gravenstein S, Malarkey W, Sheridan J (1996). Chronic stress alters the immune response to influenza virus vaccine in older adults. Proceedings of the National Academy of Sciences, USA 93, 3043-3047.
39. Kim JJ, Foy MR, Thompson RF (1996). Behavioural stress modifies hippocampal plasticity in NMDA receptor activity. Proceedings of the National Academy of Sciences USA 93, 4750-4753.
40. Kronfol E, House JC (1989). Depression HPA activity and lymphocyte function. Acta Psychiatrica Scandinavica 80, 142-147.
41. Kubera M, Symbirtsev A, Basta-Kaim A, Borycz J (1996). Effect of chronic treatment with imipramine on IL-1 and IL-2 production by splenocytes obtained from rats subjected to chronic mild stress. Polish Journal of Pharmacology 48, 503-506.
42. Kusnecov AW, Rabin BS (1994). Stressor induced alteration of immune function; mechanisms and issues. International Archives of Allergy and Applied Immunology 105, 107-121.
43. Lacosta S, Kuleycki J, Merali Z, Anisman H (1996). Behavioural endocrine and central neurochemical alterations induced by IL-1. Society of Neuroscience Abstracts 22, 2059.
44. Lapchak PA (1992). A role for IL-2 in the regulation of striatal dopaminergic function. NeuroReport 3, 165-168.
45. Leonard BE (1987). Stress the immune system and mental illness. Stress Medicine 3, 257-258.
46. Leonard BE (2001). Changes in the immune system in depression and dementia: Causal or co-incidental effects? International Journal of Developmental Neuroscience 19, 305-312.
47. Leonard BE, Tuite M (1981). Anatonical physiological and behavioural aspect of olfactory bulbectomy in the rat. International Review of Neurobiology 22, 251-286.
48. Licinio J, Wong M-L (1994). The role of inflammatory mediators in the biology of major depression. Molecular Psychiatry 4, 317-327.
49. Luine V, Villegas M, Martinez C, McEwen BS (1994). Repeated stress causes reversible impairments of spatial memory performance. Brain Research 639, 167-170.
50. McAdams C, Leonard BE (1993). Neutrophil and monocyte phagocytosis in depressed patients. Progress in Neuropharmacology and Biological Psychiatry 17, 971-984.
51. Maes M (1995). Evidence for an immune response in major depression: A review and a hypothesis. Progress in Neuropharmacology and Biological Psychiatry 19, 11-38.
52. Maes M, Bosmans E, Meltzer HY, Scharpe S, Suy E (1993a). IL-1beta: A putative mediator of HPA axis hyperactivity in major depression? American Journal of Psychiatry 150, 1189-1193.
53. Maes M, Bosmans E, Suy E, Van der Vorst C, Dejonckheere C, Minner B, Raus J (1991). Depression related disturbances in mitogen-induced lymphocyte responses IL-1beta and soluble IL-2 R production. Acta Psychiatrica Scandinavica 84, 379-386.
54. Maes M, Scharpe S, Meltzer HY, Bosmans E, Suy E (1993b). Relationships between IL-6 activity acute phase proteins and HPA axis function in severe depression. Psychiatry Research 49, 11-27.
55. Maes M, Smith R, Scharpe S (1995). The monocyte T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 20, 111-116.
56. Maes M, Song C, Lin AH, Bonaccorso S, Kenis G (1999). Negative immunoregulatory effects of antidepressants: Inhibition of INF gamma stimulation of IL-10 secretion. Neuropsychopharmacology 20, 370-379.
57. Maier SF, Watkins LR (1998). Cytokines for psychologists: Implications of bi-directional immune to brain communication for understanding behaviour mood and cognition. Psychological Review 105, 83-107.
58. Maier SF, Watkins LR, Fleshner M (1994). Psychoneuroimmunology: The interface between behaviour brain and immunity. American Psychologist 49, 1004-1017.
59. Mason JW (1971). A re-evaluation of the concept of non-specificity in stress theory. Journal of Psychiatric Research 8, 123-140.
60. Merill JE (1992). TNF-alpha IL-1 and related cytokines in brain development: Normal and pathological. Developmental Neuroscience 14, 1-10.
61. Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA (1997). Treatment of depression improves adherence to INF beta therapy for multiple sclerosis. Archives of Neurology 54, 531-533.
62. Mormede P, Dantzer R, Michaul B, Kelley K, Maoal M (1988). Influence of stressor predictability and behavioural control on lymphocyte reactivitiy antibody response and neuroendocrine activation in rats. Physiology and Behavior 43, 577-583.
63. Munck A, Naray-Fejes-Toth A (1994). Glucocorticoids and stress: Permissive and suppressive actions. Annals of the New York Academy of Sciences 746, 115-130.
64. Muscat R, Papp M, Willlner P (1992). Reversal of stress induced anhedonia by the atypical antidepressants fluoxetine and maprotiline. Psychopharmacology 109, 433-438.
65. 3H-imipramine binding sites in depressed patients. Archives of General Psychiatry 47, 337-340.
66. Nemni R, Iannaccone S, Qualtrini A, Smirne S, Sessa M, Lordi M, Erminio C, Canal N (1992). Effect of chronic treatment with recombinant IL-2 on the CNS of adult and old mice. Brain Research 591, 248-252.
67. Norris JG, Benveniste EN (1993). IL-6 production by astrocytes: Induction by the neurotransmitter norepinephrine. Journal of Neuroimmunomodulation 45, 137-146.
68. O'Neill B, Leonard BE (1990). Abnormal zymosan induced neutrophil chemilumunescence as a marker of depression. Journal of Affective Disorders 19, 265-272.
69. O'Neill B, O'Connor WT, Leonard BE (1987). Depressed neutrophil phagocytosis in the rat following olfactory reversed by chronic desipramine treatment. Medical Science Research 15, 267-268.
70. Pollak Y, Avitsur R, Canaan R, Yirmiya R (1998). Central alpha-1 adrenergic receptors are involved in mediating IL-1 induced sickness behaviour. Neuroimmunomodulation 5, 38.
71. Rausohoff RM, Benveniste EN (1996). Cytokines in the CNS. Boca Raton, New York: CRC Press.
72. Reichlin S (1993). Neuroendocrine-immune interactions. New England Journal of Medicine 329, 1246-1253.
73. Rothwell NJ, Hopkins SJ (1995). Cytokines in the nervous system: Actions and mechanisms of action. Trends in Neuroscience 18, 130-136.
74. Sakic B, Denburg JA, Denburg SD, Szechman H (1996). Blunted sensitivity to sucrose in autoimmune MRL-1pr mice: A curve shift study. Brain Research Bulletin 41, 305-311.
75. Shen Y, Comnnor TJ, Nolan Y, Kelly J, Leonard BE (1999). Differential effect of chronic antidepressant treatments on LPS induced depressive-like behavioural symptoms in the rat. Life Science 65, 1773-1786.
76. Smith RS (1991). The macrophage theory of depression. Medical Hypotheses 35, 298-305.
77. Soliven B, Albert J (1992). TNF modulates the inactivation of catecholamine secretion in cultured sympathetic neurons. Journal of Neurochemistry 58, 1073-1078.
78. Song C, Kelly J, Leonard BE (1993). Is the state of leucocyte adhesiveness/aggregation an immune marker of stress in the olfactory bulbectomised rat? Stress Medicine 9, 255-258.
79. Song C, Leonard BE (1993). Behaviour lymphocyte activity and serum corticosterone levels in olfactory bulbectomised rats following chronic desipramine treatment. Irish Journal of Medical Sciences 182, 386-387.
80. Song C, Leonard BE (1994a). Serotonin reuptake inhibitors reverse the impairments in behaviour neurotransmitters and immune function in the olfactory bulbectomised rat. Human Psychopharmacology 9, 135-146.
81. Song C, Leonard BE (1994b). An acute phase protein response in the olfactory bulbectomised rat: Effects of sertraline treatment. Medical Science Research 22, 313-314.
82. Song C, Leonard BE (1994c). The effects of lithium chloride administration on some behavioural and immunological changes in the olfactory bulbectomised rat. Journal of Psychopharmacology 8, 440-447.
83. Song C, Leonard BE (1995). The effects of olfactory bulbectomy in the rat alone and in combination with antidepressants and endogenous factors on immune function. Human Psychopharmacology 10, 7-18.
84. Song C, Leonard BE, Phillips A, Horrobin D (2000b). Changes in behaviour neurochemistry endocrine and immune functions caused by different routes and duration of IL-1 administration in the rat. International Journal of Psychopharmacology 3 (Suppl.), P 1714.
85. Song C, Rivest S, Horrobin D, Leonard BE (2000a). Endotoxin increases both gene expression and inflammation related cytokines and stress related neuroendocrines in the rat. International Journal of Psychopharmacology 3 (Suppl.), P 1713.
86. Van Riezen H, Leonard BE (1990). Effects of psychotropic drugs on the behaviour and neurochemistry of olfactory bulbectomised rats. Pharmacology and Therapeutics 47, 21-34.
87. Vitkovic L, Konsman JP, Bockaert J, Dantzer R, Homburger V, Jacque C (2000). Cytokine signals propagate through the brain. Molecular Psychiatry 5, 604-615.
88. Wiegers GJ, Reul JMHM (1998). Induction of cytokine receptors by glucocorticoids functional and pathological significance. Trends in Pharmacological Science 19, 317-321.
89. Willner P, Muscat R, Papp M (1992). Chronic mild stress induced anhedonia: A realistic model of depression. Neuroscience and Biobehavioral Reviews 16, 525-534.
90. Wrynn AS, MacSweeney CP, Franconi F, Lemaire L (2000). An in vivo magnetic resonance imaging study of the olfactory bulbectomised rat model of depression. Brain Research 879, 193-199.
91. Wu CY, Fargeas C, Nakajima T, Dalespesse G (1991). Glucocorticoids suppress the production of IL-4 by human lymphocytes. European Journal of Immunology 10, 2645-2647.
92. Xia Z, DePierre JW, Nassberger L (1996). Tricyclic antidepressants inhibit IL-6 IL-1 beta and TNF alpha release in human blood monocytes and IL-2 and INF gamma in T cells. Immunobiology 34, 37-47.
93. Xiao L, Eneroth P (1996). Tricyclic antidepressants inhibit human natural killer cells. Toxicology and Applied Pharmacology 137, 157-162.
94. Yirmiya R (1996). Endotoxin produces a depressive-like syndrome in rats. Brain Research 711, 163-174.
95. Yirmiya R, Weidenfeld J, Pollak Y, Morag A, Avitsur R, Barak O (1999). Cytokine depression due to a general medical condition and antidepressant drugs. In: Dantzer R, Wollman E, Yirmiya R (Eds.), Cytokine Stress and Depression (pp. 283-316). New York: Kluwer Academic/Plenum Publishers.
96. Zacharko RM, Anisman H (1991). Stressor provoked alterations of intracranial self-stimulation in the mesocorticolimbic system: An animal model of depression In: Willner P, Scheel-Kruger J (Eds.), The Mesolimbic System from Motivation to Action (pp. 411-442). New York: Wiley.
97. Zacharko RM, Zalcman S, MacNeil G, Andrews M, Mendella PD, Anisman H (1997). Differential effects of immunologic challenge on self-stimulation from the nucleur accumbens and the substantia nigra. Pharmacology, Biochemistry and Behavior 58, 881-886.
98. Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, Greenburg AH (1994). Cytokine specific central monoamine alterations induced by IL-1 IL-2 and IL-6. Brain Research 643, 40-49.
99. Zhou DH, Shanks N, Reichman SE, Liang RM, Kusnecov AW, Rabin BS (1996). IL-6 modulates IL-1 and stress induced activation of the HPA axis in male rats. Neuroendocrinology 63, 227-236.
100. Zhu J, Bengtsson BO, Mix E, Thoreel LH, Olsson T, Link H (1994). Effect of monoamine reuptake inhibiting antidepressants on major histocompatibility complex expression on macrophages in normal rats and rats with experimental allergic neuritis. Immunopharmacology 27, 225-244.
101. Zubareva OE, Abdurasulova IN, Bluthe R-M, Dantzer R, Kilmenko VM (1998). Effect of serotonin synthesis blockade on IL-1 beta actions in the brain of rats. Neuroimmunomodulation 5, 56.